Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | -4.98% | -9.91% | -42.64% |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 358M | Capitalization | 231M |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | -27M | EV / Sales 2024 * | 1.91 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
5.92
x | P/E ratio 2025 * |
-8.4
x | Employees | 249 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.96% |
Latest transcript on Coherus BioSciences, Inc.
1 day | -4.98% | ||
1 week | -11.98% | ||
Current month | -2.55% | ||
1 month | -12.39% | ||
3 months | -25.97% | ||
6 months | -5.45% | ||
Current year | -42.64% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.91 | -4.98% | 1,440,076 |
24-05-23 | 2.01 | -4.74% | 1,287,418 |
24-05-22 | 2.11 | +1.44% | 1,089,038 |
24-05-21 | 2.08 | 0.00% | 1,389,152 |
24-05-20 | 2.08 | -1.89% | 1,527,280 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.64% | 231M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- CHRS Stock